Collaborations

We are currently in negotiations with several companies interested in licensing the rP-nano^TM technology. Companies keen to evaluate this technology include:

• major pharmaceutical companies
• biotech companies
• diagnostics companies
• consumer product / skin care companies

Typically, licensing negotiations are preceded by an evaluation agreement where Upperton generates nanoparticle samples involving proprietary compounds from interested parties for further study. Alternatively, we can offer research licences and technology transfer services such that potential partners can generate nanoparticles in their own facilities.

More information on rP-nano^TM: technology | applications